Edwards Intuity surgical aortic valve nets CE Mark

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
Edwards Lifesciences, a developer of heart valves and hemodynamic monitoring systems, has received CE Mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).

The system, which consists of a bovine pericardial heart valve and delivery system, facilitates small incision surgery and valve deployment during AVR procedures. The company plans to begin a European launch at centers participating in post-approval clinical studies. Edwards Intuity leverages the design of Edwards' pericardial valve technology, featuring a balloon-expandable frame designed to facilitate annular placement.

The Edwards Intuity valve system is not yet available for sale or use in the U.S.

Justine Varieur Cadet

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.